Stool Softener Laxative Tablet
NDC Package 50804-855-10

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Stool Softener Laxative (docusate sodium, sennosides) tablets is take only by mouth. This formulation utilizes a tablet delivery system. Marketed by Good Sense (geiss, Destin & Dunn, Inc.), this product is identified by NDC 50804-855 and is authorized under FDA application M007.

Identification & Billing

NDC Package Code
50804-855-10
Package Description
100 TABLET in 1 BOTTLE, PLASTIC
Product Code
50804-855
11-Digit Billing Format
50804085510
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
100 EA
RxNorm Crosswalk
  • RxCUI: 998740 - sennosides 8.6 MG / docusate sodium 50 MG Oral Tablet
  • RxCUI: 998740 - docusate sodium 50 MG / sennosides, USP 8.6 MG Oral Tablet
  • RxCUI: 998740 - DOSS Sodium 50 MG / sennosides, USP 8.6 MG Oral Tablet

Clinical Specifications

Proprietary Name
Stool Softener Laxative
Non-Proprietary Name
Docusate Sodium, Sennosides
Substance Name
Docusate Sodium; Sennosides
Dosage Form
Tablet - A solid dosage form containing medicinal substances with or without suitable diluents.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
Usage Information
Take only by mouth. Doses may be taken as a single daily dose, preferably in the evening, or in divided doses. adults and children 12 years and over take 2-4 tablets daily children 6 to under 12 years of age take 1-2 tablets daily children 2 to under 6 years of age take up to 1 tablet daily children under 2 ask a doctor

Regulatory & Marketing

Labeler Name
Good Sense (geiss, Destin & Dunn, Inc.)
Product Type
Human Otc Drug
FDA Application #
M007
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
06-30-2020
End Marketing Date
06-30-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 50804-855-10 identifies a specific commercial package of 100 tablet in 1 bottle, plastic of Stool Softener Laxative, a human over the counter drug labeled by Good Sense (geiss, Destin & Dunn, Inc.). This product is billed for "EA" each discreet unit and contains an estimated amount of 100 billable units per package. This tablet is formulated for oral use and contains docusate sodium; sennosides as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Good Sense (geiss, Destin & Dunn, Inc.) on June 30, 2020.

How is this Good Sense (geiss, Destin & Dunn, Inc.) product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 50804085510. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 100 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
50804-855-10
11-Digit CMS (5-4-2)
50804-0855-10

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.